Correction to Lancet Oncol 2017; 18: 917-28

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2017 Aug.

. 2017 Aug;18(8):e433.

doi: 10.1016/S1470-2045(17)30529-6. Epub 2017 Jul 26.

No abstract available

Erratum for

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial.
Stebbing J, Baranau Y, Baryash V, Manikhas A, Moiseyenko V, Dzagnidze G, Zhavrid E, Boliukh D, Stroyakovskii D, Pikiel J, Eniu A, Komov D, Morar-Bolba G, Li RK, Rusyn A, Lee SJ, Lee SY, Esteva FJ. Stebbing J, et al. Lancet Oncol. 2017 Jul;18(7):917-928. doi: 10.1016/S1470-2045(17)30434-5. Epub 2017 Jun 4. Lancet Oncol. 2017. PMID: 28592386 Clinical Trial.